首页> 中文期刊> 《中国社区医师》 >康复新液联合自配口服液防治放疗引起口腔黏膜损伤的疗效观察

康复新液联合自配口服液防治放疗引起口腔黏膜损伤的疗效观察

         

摘要

Objective:To evaluate the clinical application value of Kangfuxin liquid combined with self-made oral liquid in the prevention and treatment of radioactive oral mucosa damage caused by radiotherapy in patients with head and neck cancer. Methods:128 patients with head and neck cancer were selected.They were treated with radiation therapy.They were randomly divided into the study group and the control group.The control group was given conventional oral nursing and self-made oral liquid.The study group was given Kangfuxin liquid on the basis of the control group.The radioactive oral mucosa reaction degrees, eating situations and ulcer healing times were compared between the two groups.Results:The oral mucosa reaction degree of the study group was significantly less than that of the control group,the eating situation was significantly better than that of the control group,the ulcer healing time was shorter than that of the control group(P<0.05).Conclusion:Kangfuxin liquid combined with self-made oral liquid can significantly reduce the radioactive oral mucosa damage caused by head and neck cancer radiotherapy, shorten the pain time,promote ulcer healing.%目的:评价康复新液联合自配口服液防治头颈部肿瘤患者放射治疗引起放射性口腔黏膜损伤的临床应用价值。方法:收治头颈部肿瘤患者128例,均给予放射性治疗,随机分为研究组与对照组。对照组给予常规口腔护理及自配口服液,研究组在对照组的基础上给予康复新液。对比两组放射性口腔黏膜反应程度、进食情况及溃疡愈合时间。结果:研究组口腔黏膜反应程度明显轻于对照组,进食情况明显优于对照组,溃疡愈合时间短于对照组(P<0.05)。结论:康复新液联合自配口服液明显减轻头颈部肿瘤放疗引起的放射性口腔黏膜损伤,缩短疼痛时间,促进溃疡愈合。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号